Contrast Media Market worth $5.9 billion by 2026
According to the new market research report “Contrast Media Market
by Type (Iodinated Contrast Media), Modality (X-Ray/CT, MRI, and
Ultrasound), Application (Radiology), End User (Hospitals), Indication
(Cancer), Route of Administration (Oral), Region - Global Forecast to
2026”, published by MarketsandMarkets™, the global Contrast Media Market
is projected to USD 5.9 billion by 2026 from USD 4.9 billion in 2021,
at a CAGR of 3.7% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911
The
Rising prevalence of chronic diseases, growing approvals of contrast
agents, rising volume of CT and MRI examinations performed, growing
number of diagnostic centers and hospitals, and availability of
reimbursement are the major factors driving the growth of the contrast
agents market.
The microbubble contrast media segment is expected
to grow at the highest CAGR during the forecast period and iodinated
contrast media accounted for the largest share in 2020.
Based on
type, the contrast media market is segmented into iodinated contrast
media, gadolinium-based contrast media, microbubble contrast media, and
barum-based contrast media. Iodinated contrast media account for the
largest share of the market. The large share of this segment can be
attributed to the growing number of angioplasty procedures performed
globally.
North America was the largest regional market for the contrast agents market in 2020
The
contrast media market is segmented into five major regions, namely,
North America, Europe, Asia Pacific, Latin America and the Middle East
& Africa (MEA). North America was the largest regional market in
2020. The large share of the North American market can be attributed to
presence of major players in the region, high prevalence of chronic
disorders, growing geriatric population, and the increasing adoption of
minimally invasive procedures.
However, the Asia Pacific contrast
media market is estimated to grow at the highest CAGR during the
forecast period. The rising prevalence of chronic diseases, the growing
demand for quality medical care, increasing healthcare spending and
government initiatives, rising disposable income, growth in the medical
device industries, and improvements in healthcare infrastructure in
Southeast Asian countries are the major factors driving the growth of
the market in the Asia Pacific.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=911
The
global contrast media market is consolidated. The prominent players
operating in this market include GE Healthcare (US), Bracco Imaging SPA
(Italy), Bayer AG (Germany), Guerbet (France), J.B. Chemicals and
Pharmaceuticals Ltd. (India), Lantheus Medical Imaging, Inc. (US),
Unijules Life Sciences Ltd. (India), and SANOCHEMIA Pharmazeutika GmbH
(Austria).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Comments
Post a Comment